nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—psoriasis	0.419	1	CbGaD
Telmisartan—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0667	0.166	CbGbCtD
Telmisartan—ABCC2—Mycophenolate mofetil—psoriasis	0.0341	0.085	CbGbCtD
Telmisartan—ABCG2—Mycophenolate mofetil—psoriasis	0.0308	0.0769	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—psoriasis	0.0267	0.0666	CbGbCtD
Telmisartan—ABCC2—Cyclosporine—psoriasis	0.0259	0.0644	CbGbCtD
Telmisartan—ABCG2—Hydrocortisone—psoriasis	0.0247	0.0617	CbGbCtD
Telmisartan—ABCG2—Cyclosporine—psoriasis	0.0234	0.0583	CbGbCtD
Telmisartan—ABCC2—Dexamethasone—psoriasis	0.017	0.0424	CbGbCtD
Telmisartan—CYP2C19—Cholecalciferol—psoriasis	0.0159	0.0396	CbGbCtD
Telmisartan—ABCG2—Dexamethasone—psoriasis	0.0154	0.0384	CbGbCtD
Telmisartan—ABCC2—Methotrexate—psoriasis	0.0137	0.0341	CbGbCtD
Telmisartan—ABCG2—Methotrexate—psoriasis	0.0124	0.0308	CbGbCtD
Telmisartan—ABCB1—Mycophenolate mofetil—psoriasis	0.0111	0.0277	CbGbCtD
Telmisartan—CYP2C19—Prednisone—psoriasis	0.011	0.0275	CbGbCtD
Telmisartan—CYP2C19—Cyclosporine—psoriasis	0.0104	0.026	CbGbCtD
Telmisartan—ABCB1—Betamethasone—psoriasis	0.00954	0.0238	CbGbCtD
Telmisartan—ABCB1—Prednisolone—psoriasis	0.00941	0.0235	CbGbCtD
Telmisartan—ABCB1—Hydrocortisone—psoriasis	0.00892	0.0222	CbGbCtD
Telmisartan—ABCB1—Prednisone—psoriasis	0.00889	0.0222	CbGbCtD
Telmisartan—ABCB1—Cyclosporine—psoriasis	0.00843	0.021	CbGbCtD
Telmisartan—CYP2C19—Dexamethasone—psoriasis	0.00688	0.0171	CbGbCtD
Telmisartan—ABCB1—Dexamethasone—psoriasis	0.00555	0.0138	CbGbCtD
Telmisartan—ABCB1—Methotrexate—psoriasis	0.00446	0.0111	CbGbCtD
Telmisartan—PPARG—dermis—psoriasis	0.00178	0.473	CbGeAlD
Telmisartan—AGTR1—Allograft Rejection—IL22—psoriasis	0.00174	0.0758	CbGpPWpGaD
Telmisartan—AGTR1—ACE Inhibitor Pathway—REN—psoriasis	0.00148	0.0648	CbGpPWpGaD
Telmisartan—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00105	0.0458	CbGpPWpGaD
Telmisartan—AGTR1—ACE Inhibitor Pathway—ACE—psoriasis	0.000927	0.0404	CbGpPWpGaD
Telmisartan—AGTR1—endothelium—psoriasis	0.000659	0.176	CbGeAlD
Telmisartan—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000651	0.0284	CbGpPWpGaD
Telmisartan—PPARG—endothelium—psoriasis	0.000542	0.144	CbGeAlD
Telmisartan—ABCB1—Allograft Rejection—IL22—psoriasis	0.00051	0.0222	CbGpPWpGaD
Telmisartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000449	0.0196	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000381	0.0166	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000349	0.0152	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—HLA-C—psoriasis	0.000329	0.0144	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL13—psoriasis	0.000327	0.0143	CbGpPWpGaD
Telmisartan—ABCG2—Iron uptake and transport—CP—psoriasis	0.000326	0.0142	CbGpPWpGaD
Telmisartan—PPARG—Differentiation of white and brown adipocyte   —LEP—psoriasis	0.000315	0.0137	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000307	0.0134	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL17A—psoriasis	0.000301	0.0131	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors—VDR—psoriasis	0.000281	0.0123	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL12B—psoriasis	0.00028	0.0122	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—HLA-E—psoriasis	0.000273	0.0119	CbGpPWpGaD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00027	0.0118	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.000268	0.0117	CbGpPWpGaD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000267	0.0116	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000265	0.0116	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000258	0.0112	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000232	0.0101	CbGpPWpGaD
Telmisartan—PPARG—skin of body—psoriasis	0.000232	0.0617	CbGeAlD
Telmisartan—Losartan—ACE—psoriasis	0.000225	1	CrCbGaD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000222	0.0097	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000219	0.00956	CbGpPWpGaD
Telmisartan—AGTR1—tendon—psoriasis	0.000214	0.0571	CbGeAlD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	0.000214	0.00932	CbGpPWpGaD
Telmisartan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000211	0.00921	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL20—psoriasis	0.000205	0.00896	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL10—psoriasis	0.000205	0.00893	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—HCAR2—psoriasis	0.000202	0.00881	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—CARM1—psoriasis	0.000201	0.00878	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL4—psoriasis	0.000199	0.00869	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000197	0.0086	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—HLA-B—psoriasis	0.000195	0.00849	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—HLA-A—psoriasis	0.00018	0.00787	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00018	0.00784	CbGpPWpGaD
Telmisartan—PPARG—tendon—psoriasis	0.000176	0.0469	CbGeAlD
Telmisartan—AGTR1—Allograft Rejection—HLA-DRB1—psoriasis	0.000165	0.00719	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—TNF—psoriasis	0.000161	0.00704	CbGpPWpGaD
Telmisartan—ABCC2—tendon—psoriasis	0.000155	0.0413	CbGeAlD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000144	0.0063	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000141	0.00616	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000138	0.00601	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000136	0.00592	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFA—psoriasis	0.000135	0.00587	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—IL6—psoriasis	0.00013	0.00568	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	0.000129	0.00564	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—NFKBIA—psoriasis	0.000129	0.00562	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.000128	0.00558	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000125	0.00546	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	0.000124	0.00542	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000121	0.00529	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IFNG—psoriasis	0.00012	0.00525	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	0.00012	0.00524	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000116	0.00508	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000115	0.00501	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—HCAR2—psoriasis	0.000114	0.00498	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—SOCS1—psoriasis	0.000114	0.00498	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000113	0.00493	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.000112	0.0049	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CXCL8—psoriasis	0.000112	0.00488	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	0.000112	0.00487	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000106	0.00461	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL20—psoriasis	0.000105	0.00458	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HCAR2—psoriasis	0.000104	0.00452	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—TARS—psoriasis	9.84e-05	0.00429	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	9.84e-05	0.00429	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	9.68e-05	0.00423	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-C—psoriasis	9.66e-05	0.00422	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL13—psoriasis	9.6e-05	0.00419	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—psoriasis	9.09e-05	0.00397	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—JUN—psoriasis	8.94e-05	0.0039	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL17A—psoriasis	8.84e-05	0.00386	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.45e-05	0.00369	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—LEP—psoriasis	8.42e-05	0.00367	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	8.36e-05	0.00365	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL12B—psoriasis	8.22e-05	0.00358	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—NFKB1—psoriasis	8.21e-05	0.00358	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.02e-05	0.0035	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TNF—psoriasis	7.79e-05	0.0034	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	7.61e-05	0.00332	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	7.49e-05	0.00327	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—STAT3—psoriasis	7.38e-05	0.00322	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NDUFA5—psoriasis	6.8e-05	0.00296	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.71e-05	0.00293	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.64e-05	0.0029	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	6.52e-05	0.00285	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—CARM1—psoriasis	6.43e-05	0.00281	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—psoriasis	6.39e-05	0.00279	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.34e-05	0.00276	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	6.31e-05	0.00276	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HCAR2—psoriasis	6.12e-05	0.00267	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CARM1—psoriasis	6.05e-05	0.00264	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	6.02e-05	0.00263	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—psoriasis	6.01e-05	0.00262	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—LEP—psoriasis	5.94e-05	0.00259	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCL20—psoriasis	5.93e-05	0.00259	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	5.92e-05	0.00258	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL4—psoriasis	5.84e-05	0.00255	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NDUFA5—psoriasis	5.8e-05	0.00253	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP2S1—psoriasis	5.78e-05	0.00252	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	5.77e-05	0.00252	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.71e-05	0.00249	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.71e-05	0.00249	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.7e-05	0.00249	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—psoriasis	5.55e-05	0.00242	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—NOS2—psoriasis	5.53e-05	0.00241	CbGpPWpGaD
Telmisartan—Myalgia—Dexamethasone—psoriasis	5.49e-05	0.000359	CcSEcCtD
Telmisartan—Body temperature increased—Cyclosporine—psoriasis	5.48e-05	0.000358	CcSEcCtD
Telmisartan—Abdominal pain—Cyclosporine—psoriasis	5.48e-05	0.000358	CcSEcCtD
Telmisartan—Anxiety—Betamethasone—psoriasis	5.47e-05	0.000358	CcSEcCtD
Telmisartan—Anxiety—Dexamethasone—psoriasis	5.47e-05	0.000358	CcSEcCtD
Telmisartan—Vomiting—Mycophenolic acid—psoriasis	5.44e-05	0.000356	CcSEcCtD
Telmisartan—Discomfort—Dexamethasone—psoriasis	5.42e-05	0.000355	CcSEcCtD
Telmisartan—Discomfort—Betamethasone—psoriasis	5.42e-05	0.000355	CcSEcCtD
Telmisartan—Dyspepsia—Hydrocortisone—psoriasis	5.42e-05	0.000355	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.41e-05	0.00236	CbGpPWpGaD
Telmisartan—Rash—Mycophenolic acid—psoriasis	5.4e-05	0.000353	CcSEcCtD
Telmisartan—Dermatitis—Mycophenolic acid—psoriasis	5.39e-05	0.000353	CcSEcCtD
Telmisartan—Pain—Prednisolone—psoriasis	5.39e-05	0.000353	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CCL20—psoriasis	5.38e-05	0.00235	CbGpPWpGaD
Telmisartan—Urticaria—Mycophenolate mofetil—psoriasis	5.37e-05	0.000351	CcSEcCtD
Telmisartan—Headache—Mycophenolic acid—psoriasis	5.36e-05	0.000351	CcSEcCtD
Telmisartan—Decreased appetite—Hydrocortisone—psoriasis	5.35e-05	0.00035	CcSEcCtD
Telmisartan—Pharyngitis—Methotrexate—psoriasis	5.35e-05	0.00035	CcSEcCtD
Telmisartan—Body temperature increased—Mycophenolate mofetil—psoriasis	5.34e-05	0.00035	CcSEcCtD
Telmisartan—Abdominal pain—Mycophenolate mofetil—psoriasis	5.34e-05	0.00035	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—psoriasis	5.32e-05	0.000348	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.32e-05	0.00232	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.32e-05	0.000348	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—TAGAP—psoriasis	5.31e-05	0.00232	CbGpPWpGaD
Telmisartan—Fatigue—Hydrocortisone—psoriasis	5.31e-05	0.000347	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.29e-05	0.00231	CbGpPWpGaD
Telmisartan—Urethral disorder—Methotrexate—psoriasis	5.28e-05	0.000346	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.28e-05	0.000346	CcSEcCtD
Telmisartan—Pain—Hydrocortisone—psoriasis	5.26e-05	0.000345	CcSEcCtD
Telmisartan—Anaphylactic shock—Dexamethasone—psoriasis	5.26e-05	0.000344	CcSEcCtD
Telmisartan—Oedema—Betamethasone—psoriasis	5.26e-05	0.000344	CcSEcCtD
Telmisartan—Oedema—Dexamethasone—psoriasis	5.26e-05	0.000344	CcSEcCtD
Telmisartan—Anaphylactic shock—Betamethasone—psoriasis	5.26e-05	0.000344	CcSEcCtD
Telmisartan—Insomnia—Triamcinolone—psoriasis	5.24e-05	0.000343	CcSEcCtD
Telmisartan—Infection—Betamethasone—psoriasis	5.23e-05	0.000342	CcSEcCtD
Telmisartan—Infection—Dexamethasone—psoriasis	5.23e-05	0.000342	CcSEcCtD
Telmisartan—Ill-defined disorder—Prednisone—psoriasis	5.21e-05	0.000341	CcSEcCtD
Telmisartan—Paraesthesia—Triamcinolone—psoriasis	5.21e-05	0.000341	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisolone—psoriasis	5.19e-05	0.00034	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—psoriasis	5.19e-05	0.00034	CcSEcCtD
Telmisartan—Anaemia—Prednisone—psoriasis	5.19e-05	0.00034	CcSEcCtD
Telmisartan—Shock—Dexamethasone—psoriasis	5.18e-05	0.000339	CcSEcCtD
Telmisartan—Shock—Betamethasone—psoriasis	5.18e-05	0.000339	CcSEcCtD
Telmisartan—Dyspnoea—Triamcinolone—psoriasis	5.17e-05	0.000338	CcSEcCtD
Telmisartan—Nervous system disorder—Betamethasone—psoriasis	5.16e-05	0.000338	CcSEcCtD
Telmisartan—Nervous system disorder—Dexamethasone—psoriasis	5.16e-05	0.000338	CcSEcCtD
Telmisartan—Thrombocytopenia—Betamethasone—psoriasis	5.15e-05	0.000337	CcSEcCtD
Telmisartan—Thrombocytopenia—Dexamethasone—psoriasis	5.15e-05	0.000337	CcSEcCtD
Telmisartan—Tachycardia—Dexamethasone—psoriasis	5.13e-05	0.000336	CcSEcCtD
Telmisartan—Tachycardia—Betamethasone—psoriasis	5.13e-05	0.000336	CcSEcCtD
Telmisartan—Angioedema—Prednisone—psoriasis	5.13e-05	0.000336	CcSEcCtD
Telmisartan—Hypersensitivity—Cyclosporine—psoriasis	5.1e-05	0.000334	CcSEcCtD
Telmisartan—Dyspepsia—Triamcinolone—psoriasis	5.1e-05	0.000334	CcSEcCtD
Telmisartan—Nausea—Mycophenolic acid—psoriasis	5.09e-05	0.000333	CcSEcCtD
Telmisartan—Hyperhidrosis—Dexamethasone—psoriasis	5.09e-05	0.000333	CcSEcCtD
Telmisartan—Hyperhidrosis—Betamethasone—psoriasis	5.09e-05	0.000333	CcSEcCtD
Telmisartan—Feeling abnormal—Hydrocortisone—psoriasis	5.07e-05	0.000332	CcSEcCtD
Telmisartan—Malaise—Prednisone—psoriasis	5.06e-05	0.000331	CcSEcCtD
Telmisartan—Vertigo—Prednisone—psoriasis	5.04e-05	0.00033	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—psoriasis	5.04e-05	0.00033	CcSEcCtD
Telmisartan—Gastrointestinal pain—Hydrocortisone—psoriasis	5.03e-05	0.00033	CcSEcCtD
Telmisartan—Syncope—Prednisone—psoriasis	5.03e-05	0.000329	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—psoriasis	5.02e-05	0.000329	CcSEcCtD
Telmisartan—Anorexia—Betamethasone—psoriasis	5.01e-05	0.000328	CcSEcCtD
Telmisartan—Anorexia—Dexamethasone—psoriasis	5.01e-05	0.000328	CcSEcCtD
Telmisartan—Urticaria—Prednisolone—psoriasis	5.01e-05	0.000328	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—psoriasis	5e-05	0.000327	CcSEcCtD
Telmisartan—Fatigue—Triamcinolone—psoriasis	5e-05	0.000327	CcSEcCtD
Telmisartan—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.98e-05	0.000326	CcSEcCtD
Telmisartan—Asthenia—Cyclosporine—psoriasis	4.97e-05	0.000325	CcSEcCtD
Telmisartan—Pain—Triamcinolone—psoriasis	4.96e-05	0.000324	CcSEcCtD
Telmisartan—Loss of consciousness—Prednisone—psoriasis	4.93e-05	0.000323	CcSEcCtD
Telmisartan—PPARG—Metabolism—CYP2S1—psoriasis	4.93e-05	0.00215	CbGpPWpGaD
Telmisartan—Hypotension—Dexamethasone—psoriasis	4.92e-05	0.000322	CcSEcCtD
Telmisartan—Hypotension—Betamethasone—psoriasis	4.92e-05	0.000322	CcSEcCtD
Telmisartan—Pruritus—Cyclosporine—psoriasis	4.9e-05	0.000321	CcSEcCtD
Telmisartan—Urticaria—Hydrocortisone—psoriasis	4.89e-05	0.00032	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—psoriasis	4.89e-05	0.00032	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—psoriasis	4.87e-05	0.000319	CcSEcCtD
Telmisartan—Body temperature increased—Hydrocortisone—psoriasis	4.87e-05	0.000319	CcSEcCtD
Telmisartan—Abdominal pain—Hydrocortisone—psoriasis	4.87e-05	0.000319	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—psoriasis	4.86e-05	0.000318	CcSEcCtD
Telmisartan—Asthenia—Mycophenolate mofetil—psoriasis	4.85e-05	0.000317	CcSEcCtD
Telmisartan—Hypertension—Prednisone—psoriasis	4.85e-05	0.000317	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.84e-05	0.00211	CbGpPWpGaD
Telmisartan—Chills—Methotrexate—psoriasis	4.84e-05	0.000316	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Betamethasone—psoriasis	4.79e-05	0.000314	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.79e-05	0.000314	CcSEcCtD
Telmisartan—Pruritus—Mycophenolate mofetil—psoriasis	4.78e-05	0.000313	CcSEcCtD
Telmisartan—Myalgia—Prednisone—psoriasis	4.78e-05	0.000313	CcSEcCtD
Telmisartan—Arthralgia—Prednisone—psoriasis	4.78e-05	0.000313	CcSEcCtD
Telmisartan—Feeling abnormal—Triamcinolone—psoriasis	4.78e-05	0.000313	CcSEcCtD
Telmisartan—Anxiety—Prednisone—psoriasis	4.76e-05	0.000312	CcSEcCtD
Telmisartan—Insomnia—Betamethasone—psoriasis	4.76e-05	0.000311	CcSEcCtD
Telmisartan—Insomnia—Dexamethasone—psoriasis	4.76e-05	0.000311	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.75e-05	0.000311	CcSEcCtD
Telmisartan—Diarrhoea—Cyclosporine—psoriasis	4.74e-05	0.00031	CcSEcCtD
Telmisartan—Paraesthesia—Dexamethasone—psoriasis	4.72e-05	0.000309	CcSEcCtD
Telmisartan—Paraesthesia—Betamethasone—psoriasis	4.72e-05	0.000309	CcSEcCtD
Telmisartan—Discomfort—Prednisone—psoriasis	4.72e-05	0.000309	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—psoriasis	4.72e-05	0.000309	CcSEcCtD
Telmisartan—Erythema—Methotrexate—psoriasis	4.69e-05	0.000307	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—psoriasis	4.69e-05	0.000307	CcSEcCtD
Telmisartan—Hypersensitivity—Prednisolone—psoriasis	4.64e-05	0.000304	CcSEcCtD
Telmisartan—Dyspepsia—Dexamethasone—psoriasis	4.63e-05	0.000303	CcSEcCtD
Telmisartan—Dyspepsia—Betamethasone—psoriasis	4.63e-05	0.000303	CcSEcCtD
Telmisartan—Diarrhoea—Mycophenolate mofetil—psoriasis	4.62e-05	0.000303	CcSEcCtD
Telmisartan—Urticaria—Triamcinolone—psoriasis	4.61e-05	0.000301	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—psoriasis	4.59e-05	0.000301	CcSEcCtD
Telmisartan—Body temperature increased—Triamcinolone—psoriasis	4.58e-05	0.0003	CcSEcCtD
Telmisartan—Dizziness—Cyclosporine—psoriasis	4.58e-05	0.0003	CcSEcCtD
Telmisartan—Anaphylactic shock—Prednisone—psoriasis	4.58e-05	0.0003	CcSEcCtD
Telmisartan—Oedema—Prednisone—psoriasis	4.58e-05	0.0003	CcSEcCtD
Telmisartan—Decreased appetite—Dexamethasone—psoriasis	4.57e-05	0.000299	CcSEcCtD
Telmisartan—Decreased appetite—Betamethasone—psoriasis	4.57e-05	0.000299	CcSEcCtD
Telmisartan—Infection—Prednisone—psoriasis	4.55e-05	0.000298	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Dexamethasone—psoriasis	4.54e-05	0.000297	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Betamethasone—psoriasis	4.54e-05	0.000297	CcSEcCtD
Telmisartan—Back pain—Methotrexate—psoriasis	4.54e-05	0.000297	CcSEcCtD
Telmisartan—Hypersensitivity—Hydrocortisone—psoriasis	4.54e-05	0.000297	CcSEcCtD
Telmisartan—Fatigue—Dexamethasone—psoriasis	4.54e-05	0.000297	CcSEcCtD
Telmisartan—Fatigue—Betamethasone—psoriasis	4.54e-05	0.000297	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.52e-05	0.00197	CbGpPWpGaD
Telmisartan—Shock—Prednisone—psoriasis	4.51e-05	0.000295	CcSEcCtD
Telmisartan—Pain—Betamethasone—psoriasis	4.5e-05	0.000294	CcSEcCtD
Telmisartan—Pain—Dexamethasone—psoriasis	4.5e-05	0.000294	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—STAT3—psoriasis	4.5e-05	0.00196	CbGpPWpGaD
Telmisartan—Nervous system disorder—Prednisone—psoriasis	4.49e-05	0.000294	CcSEcCtD
Telmisartan—Tachycardia—Prednisone—psoriasis	4.47e-05	0.000293	CcSEcCtD
Telmisartan—Dizziness—Mycophenolate mofetil—psoriasis	4.47e-05	0.000293	CcSEcCtD
Telmisartan—Skin disorder—Prednisone—psoriasis	4.45e-05	0.000291	CcSEcCtD
Telmisartan—Hyperhidrosis—Prednisone—psoriasis	4.43e-05	0.00029	CcSEcCtD
Telmisartan—Asthenia—Hydrocortisone—psoriasis	4.42e-05	0.000289	CcSEcCtD
Telmisartan—Vomiting—Cyclosporine—psoriasis	4.4e-05	0.000288	CcSEcCtD
Telmisartan—Rash—Cyclosporine—psoriasis	4.37e-05	0.000286	CcSEcCtD
Telmisartan—Anorexia—Prednisone—psoriasis	4.37e-05	0.000286	CcSEcCtD
Telmisartan—Dermatitis—Cyclosporine—psoriasis	4.36e-05	0.000286	CcSEcCtD
Telmisartan—Pruritus—Hydrocortisone—psoriasis	4.36e-05	0.000285	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—psoriasis	4.35e-05	0.000285	CcSEcCtD
Telmisartan—Headache—Cyclosporine—psoriasis	4.34e-05	0.000284	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—psoriasis	4.34e-05	0.000284	CcSEcCtD
Telmisartan—Feeling abnormal—Betamethasone—psoriasis	4.33e-05	0.000284	CcSEcCtD
Telmisartan—Feeling abnormal—Dexamethasone—psoriasis	4.33e-05	0.000284	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	4.31e-05	0.00188	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Betamethasone—psoriasis	4.3e-05	0.000282	CcSEcCtD
Telmisartan—Gastrointestinal pain—Dexamethasone—psoriasis	4.3e-05	0.000282	CcSEcCtD
Telmisartan—Vomiting—Mycophenolate mofetil—psoriasis	4.3e-05	0.000281	CcSEcCtD
Telmisartan—Hypersensitivity—Triamcinolone—psoriasis	4.27e-05	0.00028	CcSEcCtD
Telmisartan—Rash—Mycophenolate mofetil—psoriasis	4.26e-05	0.000279	CcSEcCtD
Telmisartan—Dermatitis—Mycophenolate mofetil—psoriasis	4.26e-05	0.000279	CcSEcCtD
Telmisartan—Headache—Mycophenolate mofetil—psoriasis	4.23e-05	0.000277	CcSEcCtD
Telmisartan—Malaise—Methotrexate—psoriasis	4.23e-05	0.000277	CcSEcCtD
Telmisartan—ABCG2—Metabolism—NDUFA5—psoriasis	4.23e-05	0.00184	CbGpPWpGaD
Telmisartan—Vertigo—Methotrexate—psoriasis	4.21e-05	0.000276	CcSEcCtD
Telmisartan—Diarrhoea—Hydrocortisone—psoriasis	4.21e-05	0.000276	CcSEcCtD
Telmisartan—Urticaria—Betamethasone—psoriasis	4.18e-05	0.000274	CcSEcCtD
Telmisartan—Urticaria—Dexamethasone—psoriasis	4.18e-05	0.000274	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Prednisone—psoriasis	4.17e-05	0.000273	CcSEcCtD
Telmisartan—Dizziness—Prednisolone—psoriasis	4.17e-05	0.000273	CcSEcCtD
Telmisartan—Asthenia—Triamcinolone—psoriasis	4.16e-05	0.000272	CcSEcCtD
Telmisartan—Abdominal pain—Betamethasone—psoriasis	4.16e-05	0.000272	CcSEcCtD
Telmisartan—Body temperature increased—Dexamethasone—psoriasis	4.16e-05	0.000272	CcSEcCtD
Telmisartan—Abdominal pain—Dexamethasone—psoriasis	4.16e-05	0.000272	CcSEcCtD
Telmisartan—Body temperature increased—Betamethasone—psoriasis	4.16e-05	0.000272	CcSEcCtD
Telmisartan—Insomnia—Prednisone—psoriasis	4.14e-05	0.000271	CcSEcCtD
Telmisartan—Nausea—Cyclosporine—psoriasis	4.11e-05	0.000269	CcSEcCtD
Telmisartan—Paraesthesia—Prednisone—psoriasis	4.11e-05	0.000269	CcSEcCtD
Telmisartan—Pruritus—Triamcinolone—psoriasis	4.1e-05	0.000268	CcSEcCtD
Telmisartan—Cough—Methotrexate—psoriasis	4.09e-05	0.000268	CcSEcCtD
Telmisartan—Dizziness—Hydrocortisone—psoriasis	4.07e-05	0.000266	CcSEcCtD
Telmisartan—Dyspepsia—Prednisone—psoriasis	4.03e-05	0.000264	CcSEcCtD
Telmisartan—Nausea—Mycophenolate mofetil—psoriasis	4.01e-05	0.000263	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—psoriasis	3.99e-05	0.000261	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—psoriasis	3.99e-05	0.000261	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—psoriasis	3.99e-05	0.000261	CcSEcCtD
Telmisartan—Decreased appetite—Prednisone—psoriasis	3.98e-05	0.000261	CcSEcCtD
Telmisartan—Rash—Prednisolone—psoriasis	3.97e-05	0.00026	CcSEcCtD
Telmisartan—Dermatitis—Prednisolone—psoriasis	3.97e-05	0.00026	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.97e-05	0.00026	CcSEcCtD
Telmisartan—Fatigue—Prednisone—psoriasis	3.95e-05	0.000259	CcSEcCtD
Telmisartan—Headache—Prednisolone—psoriasis	3.95e-05	0.000258	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—psoriasis	3.95e-05	0.000258	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	3.93e-05	0.00171	CbGpPWpGaD
Telmisartan—Constipation—Prednisone—psoriasis	3.92e-05	0.000256	CcSEcCtD
Telmisartan—Vomiting—Hydrocortisone—psoriasis	3.91e-05	0.000256	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—TNF—psoriasis	3.89e-05	0.0017	CbGpPWpGaD
Telmisartan—Rash—Hydrocortisone—psoriasis	3.88e-05	0.000254	CcSEcCtD
Telmisartan—Dermatitis—Hydrocortisone—psoriasis	3.88e-05	0.000254	CcSEcCtD
Telmisartan—Headache—Hydrocortisone—psoriasis	3.86e-05	0.000252	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—VDR—psoriasis	3.84e-05	0.00168	CbGpPWpGaD
Telmisartan—Dizziness—Triamcinolone—psoriasis	3.83e-05	0.000251	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—psoriasis	3.83e-05	0.000251	CcSEcCtD
Telmisartan—Infection—Methotrexate—psoriasis	3.8e-05	0.000249	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisone—psoriasis	3.77e-05	0.000247	CcSEcCtD
Telmisartan—Asthenia—Betamethasone—psoriasis	3.77e-05	0.000247	CcSEcCtD
Telmisartan—Asthenia—Dexamethasone—psoriasis	3.77e-05	0.000247	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—psoriasis	3.75e-05	0.000246	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—psoriasis	3.75e-05	0.000245	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.75e-05	0.00164	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Prednisone—psoriasis	3.75e-05	0.000245	CcSEcCtD
Telmisartan—Nausea—Prednisolone—psoriasis	3.74e-05	0.000245	CcSEcCtD
Telmisartan—Pruritus—Dexamethasone—psoriasis	3.72e-05	0.000244	CcSEcCtD
Telmisartan—Pruritus—Betamethasone—psoriasis	3.72e-05	0.000244	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.72e-05	0.00162	CbGpPWpGaD
Telmisartan—Skin disorder—Methotrexate—psoriasis	3.72e-05	0.000243	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—psoriasis	3.7e-05	0.000242	CcSEcCtD
Telmisartan—Vomiting—Triamcinolone—psoriasis	3.69e-05	0.000241	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—JUN—psoriasis	3.67e-05	0.0016	CbGpPWpGaD
Telmisartan—Nausea—Hydrocortisone—psoriasis	3.66e-05	0.000239	CcSEcCtD
Telmisartan—Rash—Triamcinolone—psoriasis	3.66e-05	0.000239	CcSEcCtD
Telmisartan—Dermatitis—Triamcinolone—psoriasis	3.65e-05	0.000239	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—psoriasis	3.65e-05	0.000239	CcSEcCtD
Telmisartan—Urticaria—Prednisone—psoriasis	3.64e-05	0.000238	CcSEcCtD
Telmisartan—Headache—Triamcinolone—psoriasis	3.63e-05	0.000238	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—psoriasis	3.62e-05	0.000237	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—psoriasis	3.62e-05	0.000237	CcSEcCtD
Telmisartan—Diarrhoea—Betamethasone—psoriasis	3.6e-05	0.000236	CcSEcCtD
Telmisartan—Diarrhoea—Dexamethasone—psoriasis	3.6e-05	0.000236	CcSEcCtD
Telmisartan—ABCG2—Metabolism—CYP2S1—psoriasis	3.59e-05	0.00157	CbGpPWpGaD
Telmisartan—Hypotension—Methotrexate—psoriasis	3.58e-05	0.000234	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IFNG—psoriasis	3.53e-05	0.00154	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.53e-05	0.00154	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Methotrexate—psoriasis	3.49e-05	0.000228	CcSEcCtD
Telmisartan—Dizziness—Dexamethasone—psoriasis	3.48e-05	0.000228	CcSEcCtD
Telmisartan—Dizziness—Betamethasone—psoriasis	3.48e-05	0.000228	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—psoriasis	3.46e-05	0.000227	CcSEcCtD
Telmisartan—Nausea—Triamcinolone—psoriasis	3.44e-05	0.000225	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—psoriasis	3.44e-05	0.000225	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—psoriasis	3.41e-05	0.000223	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—psoriasis	3.4e-05	0.000223	CcSEcCtD
Telmisartan—Hypersensitivity—Prednisone—psoriasis	3.38e-05	0.000221	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—psoriasis	3.37e-05	0.000221	CcSEcCtD
Telmisartan—Vomiting—Betamethasone—psoriasis	3.34e-05	0.000219	CcSEcCtD
Telmisartan—Vomiting—Dexamethasone—psoriasis	3.34e-05	0.000219	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—psoriasis	3.33e-05	0.000218	CcSEcCtD
Telmisartan—Rash—Betamethasone—psoriasis	3.32e-05	0.000217	CcSEcCtD
Telmisartan—Rash—Dexamethasone—psoriasis	3.32e-05	0.000217	CcSEcCtD
Telmisartan—Dermatitis—Dexamethasone—psoriasis	3.31e-05	0.000217	CcSEcCtD
Telmisartan—Dermatitis—Betamethasone—psoriasis	3.31e-05	0.000217	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—psoriasis	3.31e-05	0.000216	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—psoriasis	3.3e-05	0.000216	CcSEcCtD
Telmisartan—Headache—Betamethasone—psoriasis	3.3e-05	0.000216	CcSEcCtD
Telmisartan—Headache—Dexamethasone—psoriasis	3.3e-05	0.000216	CcSEcCtD
Telmisartan—Asthenia—Prednisone—psoriasis	3.29e-05	0.000215	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.28e-05	0.00143	CbGpPWpGaD
Telmisartan—Pain—Methotrexate—psoriasis	3.27e-05	0.000214	CcSEcCtD
Telmisartan—Pruritus—Prednisone—psoriasis	3.24e-05	0.000212	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—CCL20—psoriasis	3.18e-05	0.00139	CbGpPWpGaD
Telmisartan—Feeling abnormal—Methotrexate—psoriasis	3.15e-05	0.000206	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—IL6—psoriasis	3.14e-05	0.00137	CbGpPWpGaD
Telmisartan—Diarrhoea—Prednisone—psoriasis	3.13e-05	0.000205	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—psoriasis	3.13e-05	0.000205	CcSEcCtD
Telmisartan—Nausea—Betamethasone—psoriasis	3.12e-05	0.000205	CcSEcCtD
Telmisartan—Nausea—Dexamethasone—psoriasis	3.12e-05	0.000205	CcSEcCtD
Telmisartan—PPARG—Gene Expression—CARM1—psoriasis	3.1e-05	0.00135	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.08e-05	0.00134	CbGpPWpGaD
Telmisartan—Urticaria—Methotrexate—psoriasis	3.04e-05	0.000199	CcSEcCtD
Telmisartan—Dizziness—Prednisone—psoriasis	3.03e-05	0.000198	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.03e-05	0.00132	CbGpPWpGaD
Telmisartan—Abdominal pain—Methotrexate—psoriasis	3.03e-05	0.000198	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—psoriasis	3.03e-05	0.000198	CcSEcCtD
Telmisartan—Vomiting—Prednisone—psoriasis	2.91e-05	0.000191	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—LEP—psoriasis	2.89e-05	0.00126	CbGpPWpGaD
Telmisartan—Rash—Prednisone—psoriasis	2.89e-05	0.000189	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—psoriasis	2.89e-05	0.000189	CcSEcCtD
Telmisartan—Headache—Prednisone—psoriasis	2.87e-05	0.000188	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CXCL8—psoriasis	2.83e-05	0.00124	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.82e-05	0.00123	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CARM1—psoriasis	2.82e-05	0.00123	CbGpPWpGaD
Telmisartan—Hypersensitivity—Methotrexate—psoriasis	2.82e-05	0.000185	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—psoriasis	2.75e-05	0.00018	CcSEcCtD
Telmisartan—Nausea—Prednisone—psoriasis	2.72e-05	0.000178	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—psoriasis	2.71e-05	0.000177	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.7e-05	0.00118	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.67e-05	0.00116	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.64e-05	0.00115	CbGpPWpGaD
Telmisartan—Diarrhoea—Methotrexate—psoriasis	2.62e-05	0.000171	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.58e-05	0.00113	CbGpPWpGaD
Telmisartan—Dizziness—Methotrexate—psoriasis	2.53e-05	0.000166	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—psoriasis	2.43e-05	0.000159	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—TP53—psoriasis	2.42e-05	0.00106	CbGpPWpGaD
Telmisartan—Rash—Methotrexate—psoriasis	2.41e-05	0.000158	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—psoriasis	2.41e-05	0.000158	CcSEcCtD
Telmisartan—PPARG—Metabolism—CARM1—psoriasis	2.41e-05	0.00105	CbGpPWpGaD
Telmisartan—Headache—Methotrexate—psoriasis	2.4e-05	0.000157	CcSEcCtD
Telmisartan—CYP2C19—Metabolism—NDUFA5—psoriasis	2.34e-05	0.00102	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—psoriasis	2.29e-05	0.000997	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NDUFA5—psoriasis	2.29e-05	0.000997	CbGpPWpGaD
Telmisartan—Nausea—Methotrexate—psoriasis	2.27e-05	0.000149	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.27e-05	0.000992	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—psoriasis	2.22e-05	0.000967	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TYK2—psoriasis	2.21e-05	0.000963	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.18e-05	0.000953	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.12e-05	0.000927	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.03e-05	0.000884	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2S1—psoriasis	1.99e-05	0.000869	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2S1—psoriasis	1.94e-05	0.000848	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—VDR—psoriasis	1.85e-05	0.000807	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CARM1—psoriasis	1.76e-05	0.000766	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SOCS1—psoriasis	1.75e-05	0.000764	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CAT—psoriasis	1.74e-05	0.000757	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NFKB1—psoriasis	1.72e-05	0.000751	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—TYK2—psoriasis	1.67e-05	0.000728	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—psoriasis	1.6e-05	0.000698	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—psoriasis	1.56e-05	0.000681	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—psoriasis	1.55e-05	0.000675	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.51e-05	0.000657	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAT—psoriasis	1.48e-05	0.000646	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—psoriasis	1.45e-05	0.000634	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.45e-05	0.000633	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—psoriasis	1.35e-05	0.000588	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—psoriasis	1.34e-05	0.000584	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.32e-05	0.000574	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LEP—psoriasis	1.29e-05	0.000564	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—psoriasis	1.29e-05	0.000564	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKBIA—psoriasis	1.2e-05	0.000525	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—psoriasis	1.17e-05	0.000512	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—psoriasis	1.15e-05	0.000502	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.13e-05	0.000492	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—psoriasis	1.08e-05	0.000471	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAT—psoriasis	1.08e-05	0.000471	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.04e-05	0.000455	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.95e-06	0.000434	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TYK2—psoriasis	9.86e-06	0.00043	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CARM1—psoriasis	9.72e-06	0.000424	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CARM1—psoriasis	9.49e-06	0.000414	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.09e-06	0.000397	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—psoriasis	8.59e-06	0.000375	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—psoriasis	8.39e-06	0.000366	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—psoriasis	8.17e-06	0.000356	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—psoriasis	7.98e-06	0.000348	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKB1—psoriasis	7.68e-06	0.000335	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—psoriasis	7.31e-06	0.000319	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—psoriasis	6.97e-06	0.000304	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—psoriasis	6.91e-06	0.000301	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAT—psoriasis	5.98e-06	0.000261	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAT—psoriasis	5.84e-06	0.000255	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—psoriasis	5.27e-06	0.00023	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—psoriasis	4.82e-06	0.00021	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—psoriasis	4.65e-06	0.000203	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—psoriasis	4.54e-06	0.000198	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—psoriasis	4.05e-06	0.000177	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—psoriasis	3.95e-06	0.000172	CbGpPWpGaD
